tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market
TRVI
Trevi Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Trevi Therapeutics (TRVI) Stock News & Sentiment

Compare
470 Followers
Trevi Therapeutics’ Strong Market Potential and Revenue Opportunities Highlighted in Buy Rating
Premium
Ratings
Trevi Therapeutics’ Strong Market Potential and Revenue Opportunities Highlighted in Buy Rating
28m ago
TRVI
Promising Phase 2a Results for Trevi Therapeutics’ Haduvio Highlight Potential in RCC and IPF-Cough Markets
Premium
Ratings
Promising Phase 2a Results for Trevi Therapeutics’ Haduvio Highlight Potential in RCC and IPF-Cough Markets
7d ago
TRVI
Trevi Therapeutics: Promising Developments and Positive Outlook for Haduvio Program
Premium
Ratings
Trevi Therapeutics: Promising Developments and Positive Outlook for Haduvio Program
7d ago
TRVI
Buy Rating for Trevi Therapeutics Driven by Promising Haduvio Trial Results and Strong Efficacy in RCC and IPF Cough
Premium
Ratings
Buy Rating for Trevi Therapeutics Driven by Promising Haduvio Trial Results and Strong Efficacy in RCC and IPF Cough
8d ago
TRVI
Trevi Therapeutics’ Haduvio Phase 2b CORAL Study: A Potential Milestone in IPF Cough Treatment
Premium
Ratings
Trevi Therapeutics’ Haduvio Phase 2b CORAL Study: A Potential Milestone in IPF Cough Treatment
13d ago
TRVI
Trevi Therapeutics’ Earnings Call: Clinical Success Amid Financial Challenges
Premium
Company Announcements
Trevi Therapeutics’ Earnings Call: Clinical Success Amid Financial Challenges
15d ago
TRVI
Trevi Therapeutics: Anticipated Data Releases and Strategic Plans Reinforce Buy Rating
Premium
Ratings
Trevi Therapeutics: Anticipated Data Releases and Strategic Plans Reinforce Buy Rating
16d ago
TRVI
More TRVI News >

TRVI News on the Web

Why Trevi Therapeutics, Inc.amp;#8217;s (TRVI) Stock Is Up 5.25%
AAII
Neutral
Wall Street Analysts See a 195.05% Upside in Trevi Therapeutics (TRVI): Can the Stock Really Move This High?
Zacks
Bullish
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Pliant Therapeutics (PLRX) and Qiagen (QGEN)
TipRanks News
Neutral
Why Trevi Therapeutics, Inc.amp;#8217;s (TRVI) Stock Is Up 7.01%
AAII
Neutral
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Clover Health Investments (CLOV) and Pacira Pharmaceuticals (PCRX)
TipRanks News
Neutral
Trevi Therapeutics Inc (TRVI) Q4 2024 Earnings Call Highlights: Navigating Losses and Advancing ...
GuruFocus News
Neutral
Q4 2024 Trevi Therapeutics Inc Earnings Call Transcript
GuruFocus News
Neutral
Trevi Therapeutics added to Analyst Current Favorites list at Raymond James
The Fly
Neutral

News Score - Last 7 Days

Neutral
TRVI
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TRVI’s Media Buzz Sentiment?
Currently, no data Available
What is TRVI’s weekly average amount of articles?
Currently, no data Available
What is TRVI’s News Sentiment?
59% of articles about TRVI were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    PAHCPhibro Animal Health
    PBHPrestige Consumer Healthcare
    HCSGHealthcare Services
    THCTenet Healthcare
    AJ91DocCheck AG
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing